Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
CRISPR Therapeutics AG - Common Shares
(NQ:
CRSP
)
40.72
+0.34 (+0.84%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,348,393
Open
40.25
Bid (Size)
41.00 (24)
Ask (Size)
41.40 (1)
Prev. Close
40.38
Today's Range
39.41 - 41.02
52wk Range
39.41 - 91.10
Shares Outstanding
78,935,098
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
1 big new Green Flag for CRISPR Therapeutics' Stock
December 20, 2024
Via
The Motley Fool
Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study?
December 20, 2024
The company is still planning to move into Phase 3 testing, but analysts doubt the pain drug's future.
Via
Investor's Business Daily
Performance
YTD
-38.36%
-38.36%
1 Month
-12.03%
-12.03%
3 Month
-12.88%
-12.88%
6 Month
-29.72%
-29.72%
1 Year
-36.05%
-36.05%
More News
Read More
2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?
December 17, 2024
Via
The Motley Fool
3 Things You Need to Know if You Buy CRISPR Therapeutics Today
December 14, 2024
Via
The Motley Fool
2 Biotech Stocks to Buy Hand Over Fist in December
December 07, 2024
Via
The Motley Fool
3 of the Best Growth Stocks You Can Buy for Less than $100
December 05, 2024
Via
The Motley Fool
Where Will CRISPR Therapeutics Be in 3 Years?
November 15, 2024
Via
The Motley Fool
Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%
November 30, 2024
Via
The Motley Fool
Cathie Wood Sees Tesla As 'Largest AI Project On Earth' — Here's Why She's Not Worried About Tech Investments
November 29, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
November 26, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Editas Medicine Downgraded: Analyst Sees Limited Near-Term Catalysts
November 25, 2024
Via
Benzinga
Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?
November 24, 2024
Via
The Motley Fool
3 Monster Stocks in the Making
November 23, 2024
Via
The Motley Fool
Deciphering Disruption: Inside Cathie Wood's Latest Plays
November 16, 2024
Via
MarketBeat
Topics
Artificial Intelligence
ETFs
Exposures
Artificial Intelligence
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More
November 16, 2024
Via
The Motley Fool
3 Unstoppable Growth Stocks I'm Loading $25,000 Each Into by 2029
November 13, 2024
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
November 08, 2024
Via
The Motley Fool
Smaller Cap Biotechs Are In Season: How Are We Doing?
November 07, 2024
Via
Talk Markets
3 Companies Building Tomorrow's Game-Changing Technologies
November 05, 2024
Via
The Motley Fool
Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers
November 02, 2024
Via
The Motley Fool
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
October 31, 2024
Via
Benzinga
Topics
ETFs
Stocks
Exposures
US Equities
12 High-Growth Stocks That Could Deliver Parabolic Returns
October 28, 2024
Via
The Motley Fool
The Ultimate Biotech Stock to Buy With $50 Right Now
October 26, 2024
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
October 22, 2024
Via
The Motley Fool
Why We Buy Stocks
October 21, 2024
Via
The Motley Fool
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.